LEADER 01073nam0-22003491i-450-
001 990008095010403321
005 20050421120953.0
010   $a0-8176-3456-8
035   $a000809501
035   $aFED01000809501
035   $a(Aleph)000809501FED01
035   $a000809501
100   $a20050421d1990----km-y0itay50------ba
101 0 $aeng
102   $aUS
105   $aa-------101yy
200 1 $aPerspectives in control theory$eProceedings of the Sielpia Conference, Sielpia, Poland, September 19-24 1988$fEditors B. Jakubczyk, K. Malanowski, W. Respondek
210   $aBoston$cBirkhäuser$d1990
215   $aXIII, 352 p.$c10 ill.$d24 cm
225 1 $aProgress in systems and control theory$v2
610 0 $aControlli automatici
676   $a629.8
702  1$aJakubczyk,$bBronislaw
702  1$aMalanowski,$bK.
702  1$aRespondek,$bW
801  0$aIT$bUNINA$gRICA$2UNIMARC
901   $aBK
912   $a990008095010403321
952   $a02 51 A 27$b8167$fFINBN
959   $aFINBN
996   $aPerspectives in control theory$9753395
997   $aUNINA

LEADER 01580oam  2200409Ia 450 
001 9910697010803321
005 20230902162115.0
035   $a(CKB)5470000002384798
035   $a(OCoLC)426052505
035   $a(EXLCZ)995470000002384798
100   $a20090716d2004      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry and FDA staff$b[electronic resource] $esubmission and resolution of formal disputes regarding the timeliness of premarket review of a combination product
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Office of Combination Products,$d[2004?]
215   $a7 pages $cdigital, PDF file
300   $aTitle from PDF title page (viewed on July 16, 2009).
300   $a"05/2004"--Online title index.
517   $aGuidance for industry and FDA staff 
606   $aDispute resolution (Law)
606   $aDrug approval$xGovernment policy$zUnited States
606   $aChemotherapy, Combination
615  0$aDispute resolution (Law)
615  0$aDrug approval$xGovernment policy
615  0$aChemotherapy, Combination.
712 02$aUnited States.$bFood and Drug Administration.$bOffice of Combination Products.
712 02$aCenter for Biologics Evaluation and Research (U.S.)
801  0$bGPO
801  1$bGPO
801  2$bGPO
906   $aBOOK
912   $a9910697010803321
996   $aGuidance for industry and FDA staff$93451983
997   $aUNINA